Always document the drug name (including NDC number where required), the dose administered, and whether the route was subcutaneous, intramuscular, or intra-arterial
60% of patients achieved 20% or more weight loss, and 23% achieved 30% or more
The article on semaglutide withdrawal symptoms explains what to expect and how to manage the transition
These are anonymised composites drawn from our 2024-2026 patient panel at Bar Beauty in Toronto
It is unknown whether OZEMPIC causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of semaglutide-induced rodent thyroid Ccell tumors has not been determined
Enhancing metabolic health might lower the risk of diabetes or cardiovascular disease